Particulate matter exposure is highly correlated to pediatric asthma exacerbation

Xin Yang1, Yuanyuan Zhang1, Xueqin Zhan1

  • 1Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou 310052, China.

Aging
|July 13, 2021
PubMed

Insights

Particulate matter (PM) exposure is linked to increased pediatric asthma visits, particularly in young children. PM worsens allergic airway inflammation, suggesting Interleukin-33 (IL-33) as a potential therapeutic target for asthma exacerbation.

Area of Science:

  • Environmental Health
  • Pediatric Pulmonology
  • Immunology

Background:

  • Environmental factors significantly influence asthma's heterogeneity and severity.
  • Particulate matter (PM) is increasingly recognized for its role in asthma exacerbation.
  • Understanding the mechanisms linking PM exposure to pediatric asthma is crucial.

Purpose of the Study:

  • To investigate the correlation between ambient PM concentrations and pediatric asthma exacerbation.
  • To explore the underlying biological mechanisms of PM-induced asthma exacerbation.
  • To identify potential therapeutic targets for mitigating PM's impact on pediatric asthma.

Main Methods:

  • Analysis of a large cohort of pediatric asthma visits (N=16,779,739) linked to local PM data (2013-2017).
  • Establishment of a house dust mite (HDM)-induced allergic airway inflammation mouse model with PM intervention.
  • Assessment of the role of IL-33 in PM-aggravated airway inflammation using neutralizing antibodies.

Main Results:

  • A significant correlation was found between higher PM concentrations and increased pediatric asthma visits, especially in children under 6 years old.
  • PM exposure exacerbated HDM-induced allergic airway inflammation in the animal model.
  • Administration of an IL-33 neutralizing antibody demonstrated a protective effect against PM-induced exacerbation.

Conclusions:

  • Particulate matter is identified as a significant risk factor contributing to pediatric asthma exacerbation.
  • The study highlights the role of IL-33 in the inflammatory response to PM in asthma.
  • IL-33 emerges as a potential therapeutic target for managing PM-related pediatric asthma.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
881
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.4K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.5K